Price (delayed)
$103.8
Market cap
$129.12B
P/E Ratio
21.76
Dividend/share
$3.1
EPS
$4.77
Enterprise value
$146.15B
Gilead Sciences, Inc. /ˈɡɪliəd/, is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.